MYOV
Barclays’s Myovant Sciences Ltd. MYOV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-180,840
| Closed | -$4.88M | – | 4562 |
|
|
2022
Q4 | $4.88M | Buy |
180,840
+80,746
| +81% | +$2.18M | ﹤0.01% | 1135 |
|
|
2022
Q3 | $1.8M | Buy |
100,094
+86,093
| +615% | +$1.55M | ﹤0.01% | 1732 |
|
|
2022
Q2 | $174K | Sell |
14,001
-23,171
| -62% | -$288K | ﹤0.01% | 3216 |
|
|
2022
Q1 | $495K | Buy |
+37,172
| New | +$495K | ﹤0.01% | 2816 |
|
|
2021
Q4 | – | Sell |
-5,147
| Closed | -$116K | – | 3958 |
|
|
2021
Q3 | $116K | Buy |
5,147
+3,794
| +280% | +$85.5K | ﹤0.01% | 3173 |
|
|
2021
Q2 | $31K | Sell |
1,353
-17,183
| -93% | -$394K | ﹤0.01% | 3598 |
|
|
2021
Q1 | $381K | Sell |
18,536
-27,964
| -60% | -$575K | ﹤0.01% | 2809 |
|
|
2020
Q4 | $1.28M | Sell |
46,500
-24,700
| -35% | -$682K | ﹤0.01% | 1843 |
|
|
2020
Q3 | $1M | Sell |
71,200
-8,200
| -10% | -$115K | ﹤0.01% | 1926 |
|
|
2020
Q2 | $1.64M | Buy |
+79,400
| New | +$1.64M | ﹤0.01% | 1610 |
|
|
2020
Q1 | – | Sell |
-26,300
| Closed | -$408K | – | 4020 |
|
|
2019
Q4 | $408K | Buy |
26,300
+14,983
| +132% | +$232K | ﹤0.01% | 2800 |
|
|
2019
Q3 | $59K | Buy |
11,317
+2,234
| +25% | +$11.6K | ﹤0.01% | 3628 |
|
|
2019
Q2 | $82K | Buy |
+9,083
| New | +$82K | ﹤0.01% | 3683 |
|
|
2017
Q3 | – | Sell |
-10,877
| Closed | -$127K | – | 4187 |
|
|
2017
Q2 | $127K | Buy |
10,877
+10,734
| +7,506% | +$125K | ﹤0.01% | 2669 |
|
|
2017
Q1 | $1K | Sell |
143
-57
| -29% | -$399 | ﹤0.01% | 3948 |
|
|
2016
Q4 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 3645 |
|